Evidence method
Level · gp.fundamentals.debt_to_revenue
27.74% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Sep 30, 2023
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-23-000068General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
12.82% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
30.79% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
8.81% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
57.77% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
38.57% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
23.72% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.19% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.79% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 27.57%
- Current
- 27.74%
- Delta
- 0.17%
- Previous
- 10.00%
- Current
- 12.82%
- Delta
- 2.82%
- Previous
- 22.45%
- Current
- 30.79%
- Delta
- 8.34%
- Previous
- -2.27%
- Current
- 8.81%
- Delta
- 11.08%
- Previous
- 59.62%
- Current
- 57.77%
- Delta
- -1.84%
- Previous
- 38.66%
- Current
- 38.57%
- Delta
- -0.08%
- Previous
- 24.21%
- Current
- 23.72%
- Delta
- -0.49%
- Previous
- 2.19%
- Current
- 2.19%
- Delta
- 0.01%
- Previous
- 0.99%
- Current
- 0.79%
- Delta
- -0.21%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_DECREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.